Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 56
Filter
1.
Ultrasound Obstet Gynecol ; 63(3): 331-341, 2024 03.
Article in English | MEDLINE | ID: mdl-37552550

ABSTRACT

OBJECTIVE: To examine the external validity of the Fetal Medicine Foundation (FMF) competing-risks model for the prediction of small-for-gestational age (SGA) at 11-14 weeks' gestation in an Asian population. METHODS: This was a secondary analysis of a multicenter prospective cohort study in 10 120 women with a singleton pregnancy undergoing routine assessment at 11-14 weeks' gestation. We applied the FMF competing-risks model for the first-trimester prediction of SGA, combining maternal characteristics and medical history with measurements of mean arterial pressure (MAP), uterine artery pulsatility index (UtA-PI) and serum placental growth factor (PlGF) concentration. We calculated risks for different cut-offs of birth-weight percentile (< 10th , < 5th or < 3rd percentile) and gestational age at delivery (< 37 weeks (preterm SGA) or SGA at any gestational age). Predictive performance was examined in terms of discrimination and calibration. RESULTS: The predictive performance of the competing-risks model for SGA was similar to that reported in the original FMF study. Specifically, the combination of maternal factors with MAP, UtA-PI and PlGF yielded the best performance for the prediction of preterm SGA with birth weight < 10th percentile (SGA < 10th ) and preterm SGA with birth weight < 5th percentile (SGA < 5th ), with areas under the receiver-operating-characteristics curve (AUCs) of 0.765 (95% CI, 0.720-0.809) and 0.789 (95% CI, 0.736-0.841), respectively. Combining maternal factors with MAP and PlGF yielded the best model for predicting preterm SGA with birth weight < 3rd percentile (SGA < 3rd ) (AUC, 0.797 (95% CI, 0.744-0.850)). After excluding cases with pre-eclampsia, the combination of maternal factors with MAP, UtA-PI and PlGF yielded the best performance for the prediction of preterm SGA < 10th and preterm SGA < 5th , with AUCs of 0.743 (95% CI, 0.691-0.795) and 0.762 (95% CI, 0.700-0.824), respectively. However, the best model for predicting preterm SGA < 3rd without pre-eclampsia was the combination of maternal factors and PlGF (AUC, 0.786 (95% CI, 0.723-0.849)). The FMF competing-risks model including maternal factors, MAP, UtA-PI and PlGF achieved detection rates of 42.2%, 47.3% and 48.1%, at a fixed false-positive rate of 10%, for the prediction of preterm SGA < 10th , preterm SGA < 5th and preterm SGA < 3rd , respectively. The calibration of the model was satisfactory. CONCLUSION: The screening performance of the FMF first-trimester competing-risks model for SGA in a large, independent cohort of Asian women is comparable with that reported in the original FMF study in a mixed European population. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.


Subject(s)
Pre-Eclampsia , Pregnancy , Infant, Newborn , Female , Humans , Infant , Birth Weight , Gestational Age , Pre-Eclampsia/diagnosis , Pregnancy Trimester, First , Prospective Studies , Placenta Growth Factor
2.
J Eur Acad Dermatol Venereol ; 35(11): 2154-2165, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34379846

ABSTRACT

Childhood ultraviolet radiation exposure has a strong connection to the development of skin cancer in later life. Therefore, there have been numerous sun protection educational programmes targeted to this age group. However, the association between these have not been well established. This systematic review aims to summarize the evidence on, and assess, the effectiveness of educational programmes in improving sun protection among children under age-18. The protocol was prospectively registered in the PROSPERO database (CRD42020178264). Per PRISMA guidelines, bibliographic databases CENTRAL, OVID (EMBASE, MEDLINE, PsycINFO), LILACS, trial registries, grey literature and other sources were systematically searched for randomized controlled and clinical controlled trials published between database inception to 9 June 2020. Dual independent review of abstracts and full texts was performed. Eligible studies were assessed for methodological quality using the Cochrane risk-of-bias tool. The primary outcome was postintervention scores [standardized mean difference (SMD)] for sun protection (i) knowledge (ii) attitudes and beliefs (iii) behavioural intentions and behaviours. Sidik-Jonkman random effects meta-analysis, sensitivity and subgroup analyses were performed for specific outcomes (sunscreen and sun-safe hat use) which were sufficiently reported. 1350 publications were identified and 24 eligible trials, conducted across 8 different countries, with sufficient aggregate data were included. Small-to-moderate effects of educational programmes were observed across all sun protection outcomes of interest, but negligible effect sizes were demonstrated when specific outcomes were meta-analysed - sunscreen use, SMD 0.18 (95% CI 0.07-0.29; n = 8) and sun-safe hat use, SMD 0.08 (95% CI, 0.00-0.16; n = 6). A promising approach in the future may be to consider targeting children in secondary education with a digitally delivered interactive intervention. Current evidence, however, is insufficient to assess the effects of potential moderators and change in sun protection outcomes is likely not one-size-fits-all. Further research is warranted to direct intervention design and public policy.


Subject(s)
Skin Neoplasms , Ultraviolet Rays , Adolescent , Child , Educational Status , Humans , Skin Neoplasms/prevention & control , Sunscreening Agents
3.
Radiography (Lond) ; 27(1): 43-47, 2021 02.
Article in English | MEDLINE | ID: mdl-32540250

ABSTRACT

INTRODUCTION: The value of combined blended and experiential learning on radiographer diagnostic comment has not been explored. This study aims to examine the accuracy of image interpretation comment of radiographers who received a period of blended and experiential learning in Radiographer Abnormality Detection Systems (RADS). METHODS: We evaluated the diagnostic opinions of 13 radiographers who received a blended training and experiential learning (a process of self-learning and reflection) in RADS. Radiographers' opinions on 16,483 images were examined using the final radiologists' report as a reference standard. For each radiographer, we recorded the number of true positive, true negative, false positive and false negative opinions and MedCal® was used to calculate diagnostic performance and error rates. A t-test was used to assess whether the number of images read was associated with performance and whether the radiographers retained performance over time. RESULTS: Sensitivity ranged from 87.4 (84.0-90.2) to 98.9 (97.5-99.7) with a mean of 94.3 (93.6-94.8). Specificity varied from 96.4 (94.8-97.5) to 99.9 (99.41-100.0) with a mean of 98.2 (97.9-98.4). Diagnostic accuracy ranged from 93.1 (91.5-94.4) to 99.5 (98.9-99.8) with a mean of 96.9 (96.6-97.1). The mean false positive rate was 0.018 (range: 0.010-0.031) with a false negative rate of 0.057 (range: 0.026-0.11). There were no differences in performance between the first and latter nine months of providing opinions and the number of images reviewed was not associated with performance. CONCLUSION: Radiographers who received blended and experiential learning in RADS provide accurate diagnostic comments on plain emergency appendicular skeleton radiographs. IMPLICATION FOR PRACTICE: A combined blended and experiential learning can equip radiographers to provide diagnostic opinion on plain appendicular skeleton radiographs.


Subject(s)
Clinical Competence , Skeleton , Humans , Radiography , Singapore , X-Rays
4.
Eur Rev Med Pharmacol Sci ; 24(24): 13089-13097, 2020 12.
Article in English | MEDLINE | ID: mdl-33378062

ABSTRACT

OBJECTIVE: Recently, two influential articles that reported the association of (hydroxy)chloroquine or angiotensin converting enzyme (ACE) inhibitors and coronavirus disease 2019 (COVID-19) mortality were retracted due to significant methodological issues. Therefore, we aimed to analyze the same clinical issues through an improved research method and to find out the differences from the retracted papers. We systematically reviewed pre-existing literature, and compared the results with those of the retracted papers to gain a novel insight. MATERIALS AND METHODS: We extracted common risk factors identified in two retracted papers, and conducted relevant publication search until June 26, 2020 in PubMed. Then, we analyzed the risk factors for COVID-19 mortality and compared them to those of the retracted papers. RESULTS: Our systematic review demonstrated that most demographic and clinical risk factors for COVID-19 mortality were similar to those of the retracted papers. However, while the retracted paper indicated that both (hydroxy)chloroquine monotherapy and combination therapy with macrolide were associated with higher risk of mortality, our study showed that only combination therapy of hydroxychloroquine and macrolide was associated with higher risk of mortality (odds ratio 2.33; 95% confidence interval 1.63-3.34). In addition, our study demonstrated that use of ACE inhibitors or angiotensin receptor blockers (ARBs) was associated with reduced risk of mortality (0.77; 0.65-0.91). CONCLUSIONS: When analyzing the same clinical issues with the two retracted papers through a systematic review of randomized controlled trials and relevant cohort studies, we found out that (hydroxy)chloroquine monotherapy was not associated with higher risk of mortality, and that the use of ACE inhibitors or ARBs was associated with reduced risk of mortality in COVID-19 patients.


Subject(s)
Angiotensin Receptor Antagonists/therapeutic use , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , COVID-19/mortality , Enzyme Inhibitors/therapeutic use , Hydroxychloroquine/therapeutic use , Retraction of Publication as Topic , Age Factors , Asian People/statistics & numerical data , Black People/statistics & numerical data , COVID-19/epidemiology , COVID-19/immunology , Coronary Artery Disease/epidemiology , Databases, Factual , Diabetes Mellitus/epidemiology , Drug Therapy, Combination , Heart Failure/epidemiology , Humans , Hypertension/epidemiology , Immunocompromised Host/immunology , Information Dissemination , Macrolides/therapeutic use , Obesity/epidemiology , Organ Dysfunction Scores , Protective Factors , Pulmonary Disease, Chronic Obstructive/epidemiology , Randomized Controlled Trials as Topic , Risk Factors , SARS-CoV-2 , Severity of Illness Index , Sex Factors , Smoking/epidemiology , COVID-19 Drug Treatment
5.
Radiography (Lond) ; 26(4): e303-e311, 2020 11.
Article in English | MEDLINE | ID: mdl-32419769

ABSTRACT

Objectives: This paper aims to share our experience in reorganising our general radiography service during the coronavirus disease (COVID-19) pandemic from the viewpoint of a large tertiary referral medical centre. Key findings: Re-organization of the radiography workforce, patient segregation, and modification of routine radiographic practices are key measures to help radiographic services deal with the COVID-19 pandemic. Specific emphasis on deploying more mobile radiographic units, segregating equipment, developing consistent image acquisition workflows, and strict adherence to infection control protocols are paramount to minimize the possibility of in-hospital transmission and ensure a safe environment for both patients and staff. Streamlining communication channels between leadership and ground staff allows quick dissemination of information to ultimately facilitate safe provision of services. Conclusion: COVID-19 has drastically altered the way general radiography teams provide services. The institution of several key measures will allow hospitals to safely and sustainably provide radiographic services. To date, there have been zero incidences of radiographer healthcare worker transmission within our institution during the course of work. Implication for practice: Radiographers are facing the challenge of providing high-quality services while simultaneously minimizing pathogen exposure to staff and patients. Our experience may lend support to other radiographic services responding to the COVID-19 outbreak and serve as a blueprint for future infectious disease outbreak contingency plans.


Subject(s)
Betacoronavirus , Coronavirus Infections/prevention & control , Hospital Departments/organization & administration , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Radiography/methods , COVID-19 , Humans , SARS-CoV-2 , Tertiary Care Centers/organization & administration
6.
Ultrasound Obstet Gynecol ; 56(2): 206-214, 2020 08.
Article in English | MEDLINE | ID: mdl-31671479

ABSTRACT

OBJECTIVES: To (i) evaluate the applicability of the European-derived biomarker multiples of the median (MoM) formulae for risk assessment of preterm pre-eclampsia (PE) in seven Asian populations, spanning the east, southeast and south regions of the continent, (ii) perform quality-assurance (QA) assessment of the biomarker measurements and (iii) establish criteria for prospective ongoing QA assessment of biomarker measurements. METHODS: This was a prospective, non-intervention, multicenter study in 4023 singleton pregnancies, at 11 to 13 + 6 weeks' gestation, in 11 recruiting centers in China, Hong Kong, India, Japan, Singapore, Taiwan and Thailand. Women were screened for preterm PE between December 2016 and June 2018 and gave written informed consent to participate in the study. Maternal and pregnancy characteristics were recorded and mean arterial pressure (MAP), mean uterine artery pulsatility index (UtA-PI) and maternal serum placental growth factor (PlGF) were measured in accordance with The Fetal Medicine Foundation (FMF) standardized measurement protocols. MAP, UtA-PI and PlGF were transformed into MoMs using the published FMF formulae, derived from a largely Caucasian population in Europe, which adjust for gestational age and covariates that affect directly the biomarker levels. Variations in biomarker MoM values and their dispersion (SD) and cumulative sum tests over time were evaluated in order to identify systematic deviations in biomarker measurements from the expected distributions. RESULTS: In the total screened population, the median (95% CI) MoM values of MAP, UtA-PI and PlGF were 0.961 (0.956-0.965), 1.018 (0.996-1.030) and 0.891 (0.861-0.909), respectively. Women in this largely Asian cohort had approximately 4% and 11% lower MAP and PlGF MoM levels, respectively, compared with those expected from normal median formulae, based on a largely Caucasian population, whilst UtA-PI MoM values were similar. UtA-PI and PlGF MoMs were beyond the 0.4 to 2.5 MoM range (truncation limits) in 16 (0.4%) and 256 (6.4%) pregnancies, respectively. QA assessment tools indicated that women in all centers had consistently lower MAP MoM values than expected, but were within 10% of the expected value. UtA-PI MoM values were within 10% of the expected value at all sites except one. Most PlGF MoM values were systematically 10% lower than the expected value, except for those derived from a South Asian population, which were 37% higher. CONCLUSIONS: Owing to the anthropometric differences in Asian compared with Caucasian women, significant differences in biomarker MoM values for PE screening, particularly MAP and PlGF MoMs, were noted in Asian populations compared with the expected values based on European-derived formulae. If reliable and consistent patient-specific risks for preterm PE are to be reported, adjustment for additional factors or development of Asian-specific formulae for the calculation of biomarker MoMs is required. We have also demonstrated the importance and need for regular quality assessment of biomarker values. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.


Subject(s)
Asian People/statistics & numerical data , Pre-Eclampsia/diagnosis , Pregnancy Trimester, First/ethnology , Prenatal Diagnosis/methods , Risk Assessment/ethnology , Adult , Anthropometry , Arterial Pressure , Asia , Biomarkers/analysis , Female , Humans , Placenta Growth Factor/blood , Pre-Eclampsia/ethnology , Pregnancy , Pulsatile Flow , Quality Assurance, Health Care , Risk Assessment/methods , Ultrasonography, Prenatal , Uterine Artery/diagnostic imaging , Uterine Artery/embryology
8.
J Clin Pharm Ther ; 43(4): 581-583, 2018 Aug.
Article in English | MEDLINE | ID: mdl-29372569

ABSTRACT

WHAT IS KNOWN AND OBJECTIVE: Ketamine in a subanaesthetic dose has been shown to produce rapid antidepressant effects. Here, we describe a long-term follow-up case of a Korean patient with severe major depression who received repeated ketamine intravenous therapy (KIT). CASE DESCRIPTION: A 49-year-old woman with a 6-year history of treatment-resistant major depression was given KIT once every 1 or 2 weeks over 10 months, for a total of 36 treatments. Her mood stabilized, and she showed a nearly 50% reduction in the severity of her depressive symptom. WHAT IS NEW AND CONCLUSION: Long-term repeated KIT may be an option for alleviating treatment-resistant and relapsing major depression. Further research and large clinical trials are needed on the optimum KIT protocol, including dose, dosing interval, total number of treatments and when to stop.


Subject(s)
Antidepressive Agents/administration & dosage , Depressive Disorder, Major/drug therapy , Depressive Disorder, Treatment-Resistant/drug therapy , Ketamine/administration & dosage , Female , Follow-Up Studies , Humans , Infusions, Intravenous/methods , Middle Aged
9.
J Eur Acad Dermatol Venereol ; 32(6): 1028-1033, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29283462

ABSTRACT

BACKGROUND: Alopecia areata (AA) is an organ-specific autoimmune disease with T-cell-mediated attack of hair follicle autoantigens. As T helper 17 (Th17) cells and T regulatory (Treg) cells are crucially involved in the pathogenesis, the role of Th17 and Treg cytokines has not been studied yet. OBJECTIVE: To determine whether AA is associated with alterations in lesional and serum Th17 and Treg cytokines and studied whether they were associated with clinical type. METHODS: Scalp skin samples from 45 patients and eight normal controls were obtained for PCR specific for IFN-γ, TNF-α, TGF-ß, IL-1, IL-2, IL-4, IL-10, IL-12A, IL-13, IL-17, IL-22 and IL-23. Serum cytokines were measured from 55 patients and 15 normal controls using ELISA. RESULTS: Lesional IL-17 and IL-22 were significantly increased in patient group. Moreover, positive correlations were shown between lesional IL-17, IL-22 and disease severity. Serum IL-1, IL-17, TNF-α and TGF-ß were significantly increased, and positive correlation was shown between serum IL-17 and disease severity. CONCLUSION: These results showed significantly high Th17 cytokines in both lesion and serum in AA patients, which may highlight a functional role of these cytokines in the pathogenesis of AA.


Subject(s)
Alopecia Areata/immunology , Cytokines/blood , T-Lymphocytes, Regulatory/immunology , Th17 Cells/immunology , Alopecia Areata/classification , Alopecia Areata/pathology , Biopsy , Case-Control Studies , Cytokines/genetics , Enzyme-Linked Immunosorbent Assay , Humans , Polymerase Chain Reaction , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Scalp/metabolism , Scalp/pathology
10.
Oncogene ; 36(14): 2002-2013, 2017 04 06.
Article in English | MEDLINE | ID: mdl-27869164

ABSTRACT

Overexpression of mutant p53 is a common finding in most cancers but testicular tumours accumulate wild-type p53 (wtp53). In contrast to the accepted concept that p53 homozygous mutant mice do not accumulate mutant p53 in normal cells, our study on a mutant p53 mouse model of Li-Fraumeni syndrome harbouring the hot-spot p53R172H mutation described an elevated level of mutant p53 in non-cancerous mouse tissues. Here we use detailed immunohistochemical analysis to document the expression of p53R172H in mouse testis. In developing and adult testes, p53R172H was expressed in gonocytes, type A, Int, B spermatogonia as well as in pre-Sertoli cells and Leydig cells but was undetectable in spermatocytes and spermatids. A similar staining pattern was demonstrated for wtp53. However, the intensity of wtp53 staining was generally weaker than that of p53R172H, which indicates that the expression of p53R172H can be a surrogate marker of p53 gene transcription. Comparing the responses of wtp53 and p53R172H to irradiation, we found persistent DNA double-strand breaks in p53R172H testes and the formation of giant spermatogonia (GSG) following persistent DNA damage in p53R172H and p53-null mice. Strikingly, we found that p53R172H promotes spontaneous formation of GSG in non-stressed p53R172H ageing mice. Two types of GSG: Viable and Degenerative GSG were defined. We elucidate the factors involved in the formation of GSG: the loss of p53 function is a requirement for the formation of GSG whereas DNA damage acts as a promoting trigger. The formation of GSG does not translate to higher efficacy of testicular tumorigenesis arising from mutant p53 cells, which might be due to the presence of delayed-onset of p53-independent apoptosis.


Subject(s)
DNA Damage/physiology , Genes, p53/physiology , Mutant Proteins/physiology , Spermatogonia/pathology , Amino Acid Substitution , Animals , Animals, Newborn , Apoptosis/genetics , Arginine/genetics , Embryo, Mammalian , Histidine/genetics , Male , Mice , Mice, Transgenic , Mutant Proteins/genetics , Mutation Rate , Spermatogonia/metabolism , Testicular Neoplasms/genetics , Testicular Neoplasms/pathology , Testis/metabolism , Testis/pathology
11.
Haemophilia ; 22(6): 906-911, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27704714

ABSTRACT

INTRODUCTION: Women with inherited bleeding disorders are at increased risk for bleeding complications during pregnancy and the postpartum period, particularly postpartum haemorrhage (PPH). AIM: This retrospective study evaluates pregnancy management through the Inherited Bleeding Disorders Clinic of Southeastern Ontario, the clinical factors associated with pregnancy-related abnormal bleeding and assesses tranexamic acid use in the postpartum treatment of bleeding disorder patients. METHODS: A chart review of 62 pregnancies, from 33 women, evaluated patient characteristics (age, haemostatic factor levels) and delivery conditions (mode of delivery, postpartum treatment) in relation to abnormal postpartum bleeding. RESULTS: This cohort revealed increased risk of immediate PPH with increased age at delivery (mean age: 30.1 years with PPH, 26.5 years without PPH, P < 0.013), and birth by vaginal delivery (P < 0.042). Low von Willebrand factor (VWF) antigen or factor VIII (FVIII) in the third trimester was not associated with an increased risk of PPH; however, low VWF:RCo was associated with increased immediate PPH despite treatment with continuous factor infusion (P < 0.042). Women treated with tranexamic acid postpartum had less severe bleeding in the 6-week postpartum (P < 0.049) with no thrombotic complications. CONCLUSIONS: This study contributes to the growing body of work aimed at optimizing management of bleeding disorder patients through pregnancy and the postpartum period, showing patients are at a higher risk of PPH as they age. Risk factors such as low third trimester VWF:RCo have been identified. Treatment with tranexamic acid in the postpartum period is associated with a reduced incidence of abnormal postpartum bleeding.


Subject(s)
Hemorrhagic Disorders/etiology , Postpartum Hemorrhage/etiology , von Willebrand Diseases/drug therapy , von Willebrand Factor/therapeutic use , Adult , Female , Humans , Pregnancy , Retrospective Studies , Risk Factors
13.
Genet Mol Res ; 14(3): 9667-74, 2015 Aug 14.
Article in English | MEDLINE | ID: mdl-26345899

ABSTRACT

Alopecia areata (AA) is a common disease, which causes hair loss in humans. AA has a genetically complex inheritance. This study investigated the possible correlations between single nucleotide polymorphisms (SNPs) in the promoter regions of the chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) (CXCL1) and chemokine (C-X-C motif) ligand 2 (CXCL2) genes and the development of AA in the Korean population. Two hundred and thirty-five AA patients and 240 control subjects were recruited. The specific SNPs occurring in the promoter regions of the CXCL1 and CXCL2 genes (rs3117604, -429C/T and rs3806792, -264T/C, respectively) were genotyped. All data obtained was evaluated using the SNPStats, SPSS 18.0, and the Haploview v.4.2 software platforms. The Odd's ratios (OR), 95% confidence intervals (CI), and P values were calculated using multiple logistic regression models. Analyses of the genetic sequences obtained revealed a significant correlation between the two SNPs and the development of AA (rs3117604, P = 0.0009 in co-dominant model 1, P = 0.01 in co-dominant model 2, P = 0.004 in the dominant model, P = 0.005 in the log-additive model, P = 0.012 in allele distribution; rs3806792, P = 0.036 in co-dominant model 2, P = 0.0046 in the log-additive model). The TT and CC haplotypes were also observed to show a significant association with increased risk of AA (TT haplotype, P = 0.0018; CC haplotype, P = 0.0349). Our data suggests that the CXCL1 and CXCL2 genes may be associated with AA susceptibility.


Subject(s)
Alopecia Areata/genetics , Chemokine CXCL1/genetics , Chemokine CXCL2/genetics , Genetic Predisposition to Disease , Polymorphism, Single Nucleotide , Promoter Regions, Genetic , Adolescent , Adult , Alleles , Alopecia Areata/diagnosis , Alopecia Areata/epidemiology , Case-Control Studies , Female , Gene Frequency , Genetic Association Studies , Genotype , Haplotypes , Humans , Male , Odds Ratio , Republic of Korea/epidemiology , Risk , Young Adult
14.
Genet Mol Res ; 14(4): 18820-7, 2015 Dec 29.
Article in English | MEDLINE | ID: mdl-26782532

ABSTRACT

The transporter 1 ATP-binding cassette sub-family B (MDR/TAP) gene (TAP1) is located in the major histocompatibility complex class II region, and forms a heterodimer that plays a key role in endogenous antigen presentation pathways. Investigation of polymorphisms identified in these loci has revealed an association with several autoimmune disorders. Alopecia areata (AA) is a common autoimmune disease resulting from T cell-induced damage to hair follicles. The present study documents for the first time a comparison between the allelic and genotypic frequencies of TAP1 single nucleotide polymorphisms (SNPs) in patients with AA and those of a control group, using a direct sequencing method. Our results suggest an association between a promoter SNP (rs2071480) and susceptibility to this disease.


Subject(s)
ATP-Binding Cassette Transporters/genetics , Alopecia Areata/genetics , Genetic Predisposition to Disease , Hair Follicle/metabolism , Polymorphism, Single Nucleotide , Promoter Regions, Genetic , ATP Binding Cassette Transporter, Subfamily B, Member 2 , ATP-Binding Cassette Transporters/immunology , Adolescent , Adult , Alleles , Alopecia Areata/ethnology , Alopecia Areata/immunology , Alopecia Areata/pathology , Asian People , Case-Control Studies , Female , Gene Expression , Gene Frequency , Genetic Loci , Hair Follicle/immunology , Hair Follicle/pathology , Humans , Male , Middle Aged , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , T-Lymphocytes/pathology
15.
Cell Death Dis ; 4: e915, 2013 Nov 07.
Article in English | MEDLINE | ID: mdl-24201814

ABSTRACT

The phenotypic transformation of well-differentiated epithelial carcinoma into a mesenchymal-like state provides cancer cells with the ability to disseminate locally and to metastasise. Different degrees of epithelial-mesenchymal transition (EMT) have been found to occur in carcinomas from breast, colon and ovarian carcinoma (OC), among others. Numerous studies have focused on bona fide epithelial and mesenchymal states but rarely on intermediate states. In this study, we describe a model system for appraising the spectrum of EMT using 43 well-characterised OC cell lines. Phenotypic EMT characterisation reveals four subgroups: Epithelial, Intermediate E, Intermediate M and Mesenchymal, which represent different epithelial-mesenchymal compositions along the EMT spectrum. In cell-based EMT-related functional studies, OC cells harbouring an Intermediate M phenotype are characterised by high N-cadherin and ZEB1 expression and low E-cadherin and ERBB3/HER3 expression and are more anoikis-resistant and spheroidogenic. A specific Src-kinase inhibitor, Saracatinib (AZD0530), restores E-cadherin expression in Intermediate M cells in in vitro and in vivo models and abrogates spheroidogenesis. We show how a 33-gene EMT Signature can sub-classify an OC cohort into four EMT States correlating with progression-free survival (PFS). We conclude that the characterisation of intermediate EMT states provides a new approach to better define EMT. The concept of the EMT Spectrum allows the utilisation of EMT genes as predictive markers and the design and application of therapeutic targets for reversing EMT in a selective subgroup of patients.


Subject(s)
Anoikis/drug effects , Cadherins/metabolism , Epithelial-Mesenchymal Transition/drug effects , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/metabolism , Animals , Antineoplastic Agents/therapeutic use , Benzodioxoles/therapeutic use , Cadherins/genetics , Cell Line, Tumor , Enzyme-Linked Immunosorbent Assay , Female , Fluorescent Antibody Technique , Humans , Mice , Quinazolines/therapeutic use , Xenograft Model Antitumor Assays
16.
Acta Anaesthesiol Scand ; 57(5): 613-22, 2013 May.
Article in English | MEDLINE | ID: mdl-23496092

ABSTRACT

BACKGROUND: Laparoscopic surgery performed with a patient in the Trendelenburg position is known to have adverse effects on pulmonary gas exchange and respiratory mechanics. We supposed that prolonged inspiratory time can improve gas exchange at lower airway pressure. METHODS: One hundred patients undergoing gynaecologic laparoscopic surgery were randomly assigned to one of four groups: conventional inspiratory-to-expiratory (I : E) ratio (Group 1 : 2), I : E ratio of 1 : 1 (Group 1 : 1), 2 : 1 (Group 2 : 1), or 1 : 2 with external positive end-expiratory pressure (PEEP) of 5 cmH2 O (Group 1 : 2 PEEP). Tidal volume was set to 6 ml/kg, and I : E ratio was adjusted at the onset of pneumoperitoneum. Arterial blood gas analysis with measurements of partial pressure of arterial oxygen/fraction of inspired oxygen (PaO2 /FiO2 ), and physiologic dead space-to-tidal volume ratio (VD /VT ) was performed 15 min after anaesthetic induction (T1), and 30 (T2) and 60 min (T3) after onset of CO2 insufflation. RESULTS: PaO2 /FiO2 at T3 in Groups 1 : 1, 2 : 1, and 1 : 2 PEEP were higher than Group 1 : 2. The partial pressure of arterial carbon dioxide at T3 in Group 2 : 1 was lower than the other groups. The VD /VT at T2 and T3 were lower in Groups 1 : 1 and 2 : 1 than Groups 1 : 2 and 1 : 2 PEEP. Peak or plateau airway pressure was higher in Group 1 : 2 PEEP than the other groups. CONCLUSIONS: A prolonged inspiratory time demonstrated a beneficial effect on oxygenation. Furthermore, it showed better CO2 elimination without elevating the peak or plateau airway pressure compared with applying external PEEP. In terms of gas exchange and respiratory mechanics, a prolonged inspiratory time appears to be superior to applying external PEEP in patients undergoing laparoscopic surgery in the Trendelenburg position.


Subject(s)
Laparoscopy , Pulmonary Gas Exchange/physiology , Respiration, Artificial/methods , Respiratory Mechanics/physiology , Adult , Carbon Dioxide/blood , Female , Humans , Oxygen/blood , Positive-Pressure Respiration , Prospective Studies , Single-Blind Method , Tidal Volume/physiology , Time Factors
17.
Transplant Proc ; 44(2): 380-3, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22410022

ABSTRACT

BACKGROUND: Intermittent inflow occlusion (IIO) is a safe, effective method to reduce blood loss during liver resection and preserve function even among patients with underlying diseases such as steatosis and cirrhosis. Therefore, we evaluated the impact of IIO on postoperative liver function tests (LFT) and on morbidity among living liver donors undergoing a right hepatectomy, including donors with mild degrees (5%-30%) of macrovesicular steatosis (MaS). METHODS: We retrospectively reviewed the medical records of 186 living liver donors from August 2008 to September 2010. Donors were divided into two groups according to group IIO (n=81) versus Controls (no IIO, n=105). Within each group, donors were subdivided to evaluate Peak values of LFTs and complications into according the degree of MaS: group I_5 (n=36); IIO+<5% MaS, group I_30 (n=45); IIO+5%-30% MaS, group C_5 (n=55); Control+<5% MaS, and group C_30 (n=50); Control+5%-30% MaS. RESULTS: Peak aspartate aminotransferase (AST) and alanine aminotransferase (ALT) among IIO were significantly higher than Non-IIO. These values in groups I_5 and I_30 were significantly higher than groups C_5 and C_30, respectively (all, P<.01). The overall postoperative complications were comparable between groups IIO and Non-IIO, but significantly higher among group I_30 than groups I_5 (P=0.024) and C_30 (P=.012). CONCLUSIONS: Application of IIO in donors with mild macrosteatosis undergoing right hepatectomy showed significantly higher postoperative peak liver functions tests and number of overall complications than those without IIO.


Subject(s)
Blood Loss, Surgical/prevention & control , Fatty Liver/complications , Hepatectomy/methods , Liver Diseases/prevention & control , Liver Transplantation/methods , Living Donors , Adult , Alanine Transaminase/blood , Analysis of Variance , Aspartate Aminotransferases/blood , Bilirubin/blood , Biomarkers/blood , Chi-Square Distribution , Constriction , Fatty Liver/diagnosis , Hepatectomy/adverse effects , Humans , Linear Models , Liver Diseases/blood , Liver Diseases/etiology , Liver Function Tests , Liver Transplantation/adverse effects , Republic of Korea , Retrospective Studies , Severity of Illness Index , Treatment Outcome , Young Adult
18.
Transplant Proc ; 44(2): 512-5, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22410058

ABSTRACT

PURPOSE: The aim of this study was to evaluate the impact of macrovesicular (MaS) and microvesicular steatosis (MiS) on postoperative liver function in living donors undergoing right hepatectomy. METHODS: We retrospectively reviewed the medical records of 450 living liver donors who underwent right hepatectomy between 2000 and 2009. First, we divided the donors into two groups according to the degree of MaS regardless of MiS: group MaS_5 (n=250), donors with <5% MaS and group MaS_30 (n=200), donors with 5% to 30% MaS. Second, we stratified donors according to the degree of MiS regardless of Mas: group MiS_5 (n=163), donors with <5% MiS, group MiS_30 (n=287), and 5%-30% MiS. We evaluated the peak values of total bilirubin (TB), aspartate aminotransferase (AST), and alanine aminotransferase (ALT) until the thirtieth postoperative day (POD). Next, we assessed the relation between MaS or MiS and postoperative peak liver function tests using regression analysis. RESULTS: Peak values of postoperative AST (227±77 vs 203±67, respectively) and ALT (232±85 vs. 198±72, respectively) were significantly higher in the group MaS_30 than MaS_5. Similarly, the peak values of AST (225±80 vs 194±50, respectively) and ALT (228±85 vs 186±60, respectively) were significantly higher in the group MiS_30 than the group MiS_5. Regression models showed a significant modifying influence of MiS (P<0.001) on postoperative peak ALT levels in addition to MaS (P<.036), suggesting have comparable influences of both MiS and MaS on hepatic injury. CONCLUSION: Our results suggested that a mild degree of either MaS or MiS was associated with higher postoperative peak AST and ALT values. A regression analysis showed both MaS and MiS to display similar impacts on postoperative liver functions after living donor right hepatectomy.


Subject(s)
Fatty Liver/diagnosis , Hepatectomy , Liver Transplantation , Living Donors , Adult , Alanine Transaminase/blood , Aspartate Aminotransferases/blood , Bilirubin/blood , Biomarkers/blood , Chi-Square Distribution , Clinical Enzyme Tests , Fatty Liver/complications , Female , Hepatectomy/adverse effects , Humans , Linear Models , Liver Transplantation/adverse effects , Male , Postoperative Complications/blood , Postoperative Complications/diagnosis , Postoperative Complications/etiology , Predictive Value of Tests , ROC Curve , Republic of Korea , Retrospective Studies , Risk Assessment , Risk Factors , Severity of Illness Index , Time Factors , Treatment Outcome , Young Adult
19.
Anaesthesia ; 67(1): 19-22, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21972884

ABSTRACT

We investigated the forces required to remove thoracic epidural catheters to determine the effect of patient position on removal. Eighty-four patients undergoing open thoracotomy and thoracic patient-controlled epidural analgesia were enrolled. Catheterisation was performed under fluoroscopic guidance before surgery, and the patients were allocated to one of three position groups for removal: prone; sitting; and lateral. On the third postoperative day, the peak tension during withdrawal in the assigned position was measured. No differences in mean (SD) forces were found between groups: prone 1.61 (0.39) N, supine 1.62 (0.61) N and lateral 1.36 (0.56) N (p = 0.140). The withdrawal forces required to remove thoracic epidural catheters were not affected by the position. Thus, the position for removal can be determined by patient's choice and clinical judgement.


Subject(s)
Analgesia, Epidural/methods , Anesthesia, Epidural/methods , Patient Positioning , Posture/physiology , Adult , Age Factors , Aged , Analgesia, Epidural/instrumentation , Analgesia, Patient-Controlled , Analgesics, Opioid/administration & dosage , Analgesics, Opioid/therapeutic use , Anesthesia, Epidural/instrumentation , Anesthetics, Local/administration & dosage , Anesthetics, Local/therapeutic use , Body Height/physiology , Body Mass Index , Bupivacaine/administration & dosage , Bupivacaine/therapeutic use , Catheterization , Catheters , Device Removal , Epidural Space/diagnostic imaging , Female , Fluoroscopy , Humans , Hydromorphone/administration & dosage , Hydromorphone/therapeutic use , Male , Middle Aged , Pain, Postoperative/drug therapy , Prone Position/physiology , Prospective Studies , Sample Size , Sex Factors , Thoracic Vertebrae
20.
J Int Med Res ; 39(5): 1798-807, 2011.
Article in English | MEDLINE | ID: mdl-22117980

ABSTRACT

This retrospective study used abdominal computed tomography (CT) scan images to determine the optimal safe oblique angle for fluoroscopy in fluoroscope-assisted coeliac plexus block (CPB). Abdominal CT scans from 131 patients were included in the study: 42 patients with cancer of the pancreas head, 45 with cancer of the pancreas body and tail and 44 with chronic pancreatitis. The oblique angle and entry distance from the midline were measured at the T12 and L1 levels, and the safe angle range that avoided puncture of the organs was also measured. The optimal angle varied between the T12 and L1 levels, and between the right and left sides at the T12 level. There was no difference in the oblique angle between the patient groups. The optimal oblique angle for fluoroscopy was determined to be 17° for right T12, 18° for left T12, and 19° for both left and right L1.


Subject(s)
Abdominal Pain/therapy , Autonomic Nerve Block/methods , Celiac Plexus/diagnostic imaging , Pain, Intractable/therapy , Abdominal Pain/etiology , Aged , Aged, 80 and over , Female , Fluoroscopy , Humans , Lumbosacral Region/diagnostic imaging , Male , Middle Aged , Pain, Intractable/etiology , Pancreatic Neoplasms/complications , Pancreatic Neoplasms/physiopathology , Pancreatitis, Chronic/complications , Pancreatitis, Chronic/physiopathology , Radiography, Thoracic , Retrospective Studies , Spine/diagnostic imaging , Therapy, Computer-Assisted , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...